In particular, constitutive activation of STAT3 has been shown to play an essential role not only in acute myeloid leukemia, Hodgkin lymphoma, nasal-type natural killer cell lymphoma but also gastric cancer, ovarian cancer and breast cancer [20–23]. Here, STAT3 is linked to breast carcinoma.